Common Cold Sore Virus May Disrupt the Brain’s Defenses, Mouse Study Finds

Herpes simplex virus type 1 is best known for causing recurring cold sores, but mounting evidence suggests its impact can reach far deeper into the body. Researchers now show the common virus can infiltrate the brain and disrupt its resident immune cells, potentially raising the risk of neurodegenerative disease.

HSV-1 infects an estimated billions of people worldwide, often lying dormant after the initial infection. Past population studies have linked the virus to a higher likelihood of dementia and Alzheimer’s disease, but the biological mechanisms behind this association have been unclear.

Microglia pushed into emergency mode

A new study published in PLOS Pathogens examined how HSV-1 interacts with microglia, the brain’s specialized immune cells. Microglia constantly patrol neural tissue, clearing debris, removing damaged cells, and fine-tuning connections between neurons to keep the brain healthy.

Scientists at the University of Colorado Anschutz infected mice with HSV-1 and analyzed their brains six days later using gene expression profiling and imaging. They found the virus was largely confined to specific areas of the brainstem, but microglial cells near those sites appeared highly activated.

In infected animals, microglia showed a surge in interferon signaling, a powerful antiviral response in which cells release proteins that warn and prime neighboring cells. The proportion of interferon-responsive microglia was more than 30 times higher than in control mice receiving a mock treatment.

Normal maintenance duties interrupted

While this alarm state may help control the virus, it appeared to come at a cost. Microglia from infected brains showed reduced activity of genes involved in everyday maintenance tasks such as monitoring the neural environment, communicating with other brain cells, and clearing toxic material.

The authors describe this as a redistribution of microglial identities, where cells are pushed away from homeostatic roles into a highly specialized antiviral mode. Such a shift could, in theory, allow damaging proteins and cellular waste to accumulate over time.

The team notes that the loss of normal microglial programs has been documented in multiple neurological conditions, including Alzheimer’s disease and multiple sclerosis. Their data raise the possibility that viral infection might help initiate microglial state changes that resemble those seen in these disorders.

What this means for dementia risk

The new findings were obtained in a small group of mice that were euthanized shortly after infection, so the study cannot show whether the animals would have gone on to develop neurodegeneration. It also remains unknown how long the microglial reprogramming persists once HSV-1 is controlled.

However, the results align with epidemiological studies in humans linking HSV-1 and chronic brain inflammation. Prior research suggests that people with evidence of repeated HSV-1 reactivation may face a higher risk of dementia, and some data hint that antiviral drugs could reduce that risk.

Researchers caution that association does not prove causation, and many individuals with HSV-1 will never develop dementia. Genetic factors, cardiovascular health, and other infections all contribute to overall brain risk, making the picture complex.

Next steps for researchers

The authors say it is critical to examine how durable these microglial state changes are after acute HSV-1 infection and whether similar patterns appear in human brain tissue. Long-term animal studies could reveal whether repeated viral reactivation accelerates cognitive decline.

Future clinical work will also focus on whether early antiviral treatment or vaccines might reduce chronic neuroinflammation linked to HSV-1. As global populations age, clarifying the role of common viral infections in dementia has become a major public health priority.

The study adds to a growing body of work suggesting that what happens during an acute viral infection may echo in the brain for years. Understanding how microglia are pushed off their normal course could help identify new strategies to prevent or slow neurodegenerative disease.